Creo Medical announced in June important upper gastrointestinal (GI) procedures EU clearance for its flagship product Speedboat Inject — its dual-energy endoscopy tool which uses radiofrequency and microwave energy for integrated cutting and coagulation functionality. Before, Speedboat was only cle
30 Jun 2023
Upper GI opportunities opened up
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Upper GI opportunities opened up
Creo Medical Group Plc (CREO:LON) | 35.6 0.9 8.0% | Mkt Cap: 128.9m
- Published:
30 Jun 2023 -
Author:
Robin Davison | John Savin PhD | Daniel Appiah -
Pages:
5
Creo Medical announced in June important upper gastrointestinal (GI) procedures EU clearance for its flagship product Speedboat Inject — its dual-energy endoscopy tool which uses radiofrequency and microwave energy for integrated cutting and coagulation functionality. Before, Speedboat was only cle